Location: Las Vegas, NV
CIK: 0002106939 · Show all filings
Period: Q2 2026 (← Previous) (Next →)
Filing Date: Jul 9, 2026
Total Value: $188M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 570,000 | $90.2M | 48.0% | $158.25 | $130.01 | +21.7% | ST STR SP BIOT | 78464A870 |
| SGOV | ISHARES TR | 700,000 | $70.47M | 37.5% | $100.67 | $100.50 | +0.2% | 0-3 MTH TREASURY | 46436E718 |
| RPRX | ROYALTY PHARMA PLC | 11,000 | $617K | 0.3% | $56.07 | $38.13 | +47.0% | SHS CLASS A | G7709Q104 |
| NRIX | NURIX THERAPEUTICS INC | 25,000 | $607K | 0.3% | $24.26 | $14.37 | +68.9% | COM | 67080M103 |
| INCY | INCYTE CORP | 5,300 | $601K | 0.3% | $113.36 | $96.76 | +17.2% | COM | 45337C102 |
| ARGX | ARGENX SE | 641 | $595K | 0.3% | $927.77 | $854.69 | +8.6% | SPONSORED ADR | 04016X101 |
| IRON | DISC MEDICINE INC | 8,000 | $585K | 0.3% | $73.14 | $69.40 | +5.4% | COM | 254604101 |
| RAPP | RAPPORT THERAPEUTICS INC | 14,000 | $583K | 0.3% | $41.67 | $27.68 | +50.6% | COM | 75383L102 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 17,000 | $568K | 0.3% | $33.39 | $22.52 | +48.3% | COM | 90400D108 |
| TRVI | TREVI THERAPEUTICS INC | 30,000 | $560K | 0.3% | $18.65 | $11.19 | +66.6% | COM | 89532M101 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 23,000 | $557K | 0.3% | $24.20 | $19.12 | +26.6% | COM | 61225M102 |
| TGTX | TG THERAPEUTICS INC | 10,000 | $549K | 0.3% | $54.94 | $32.66 | +68.2% | COM | 88322Q108 |
| HALO | HALOZYME THERAPEUTICS INC | 7,000 | $548K | 0.3% | $78.27 | $67.27 | +16.4% | COM | 40637H109 |
| IONS | IONIS PHARMACEUTICALS INC | 6,800 | $539K | 0.3% | $79.29 | $75.30 | +5.3% | COM | 462222100 |
| PHVS | PHARVARIS N V | 15,000 | $519K | 0.3% | $34.58 | $24.09 | +43.6% | COM | N69605108 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 19,700 | $517K | 0.3% | $26.22 | $25.60 | +2.4% | COM | 03969K108 |
| AUPH | AURINIA PHARMACEUTICALS INC | 30,000 | $509K | 0.3% | $16.97 | $14.18 | +19.7% | COM | 05156V102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 3,000 | $506K | 0.3% | $168.53 | $144.51 | +16.6% | COM | 64125C109 |
| IMVT | IMMUNOVANT INC | 13,000 | $501K | 0.3% | $38.53 | $22.30 | +72.8% | COM | 45258J102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 19,766 | $500K | 0.3% | $25.30 | $23.90 | +5.9% | COM | 004225108 |
| PTCT | PTC THERAPEUTICS INC | 6,000 | $489K | 0.3% | $81.57 | $72.67 | +12.2% | COM | 69366J200 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 13,000 | $484K | 0.3% | $37.21 | $26.34 | +41.3% | COM NEW | 15117B202 |
| IMCR | IMMUNOCORE HLDGS PLC | 15,141 | $481K | 0.3% | $31.75 | $35.16 | -9.7% | ADS | 45258D105 |
| DFTX | DEFINIUM THERAPEUTICS INC | 10,000 | $470K | 0.3% | $47.04 | $16.97 | +177.2% | COM SHS | 24477V105 |
| COGT | COGENT BIOSCIENCES INC | 12,000 | $464K | 0.2% | $38.70 | $28.11 | +37.7% | COM | 19240Q201 |
| KYMR | KYMERA THERAPEUTICS INC | 4,000 | $459K | 0.2% | $114.67 | $67.53 | +69.8% | COM | 501575104 |
| DYN | DYNE THERAPEUTICS INC | 20,000 | $444K | 0.2% | $22.21 | $18.94 | +17.3% | COM | 26818M108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,465 | $441K | 0.2% | $301.03 | $432.30 | -30.4% | COM | 02043Q107 |
| TARS | TARSUS PHARMACEUTICALS INC | 7,000 | $441K | 0.2% | $62.94 | $74.33 | -15.3% | COM | 87650L103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 20,000 | $437K | 0.2% | $21.86 | $17.45 | +25.3% | COM | 87164F105 |
| EXEL | EXELIXIS INC | 8,000 | $435K | 0.2% | $54.41 | $41.37 | +31.5% | COM | 30161Q104 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 11,000 | $412K | 0.2% | $37.42 | $44.52 | -15.9% | COM | 22663K107 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 12,000 | $407K | 0.2% | $33.89 | $36.39 | -6.9% | ORDINARY SHARES | N62509109 |
| ASND | ASCENDIS PHARMA A/S | 1,500 | $400K | 0.2% | $266.72 | $233.60 | +14.2% | ORD SHS | K08588103 |
| LQDA | LIQUIDIA CORPORATION | 5,000 | $399K | 0.2% | $79.73 | $53.60 | +48.8% | COM NEW | 53635D202 |
| STOK | STOKE THERAPEUTICS INC | 12,000 | $393K | 0.2% | $32.72 | $30.06 | +8.8% | COM | 86150R107 |
| VKTX | VIKING THERAPEUTICS INC | 10,000 | $390K | 0.2% | $39.01 | $35.37 | +10.3% | COM | 92686J106 |
| IMNM | IMMUNOME INC | 18,000 | $381K | 0.2% | $21.19 | $17.55 | +20.7% | COM | 45257U108 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,000 | $368K | 0.2% | $122.58 | $81.85 | +49.8% | COM | 74366E102 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 10,000 | $364K | 0.2% | $36.41 | $32.88 | +10.7% | COM | 413197104 |
| ELVN | ENLIVEN THERAPEUTICS INC | 7,000 | $355K | 0.2% | $50.75 | $27.70 | +83.2% | COM | 29337E102 |
| SYRE | SPYRE THERAPEUTICS INC | 4,000 | $355K | 0.2% | $88.78 | $26.13 | +239.8% | COM NEW | 00773J202 |
| NTLA | INTELLIA THERAPEUTICS INC | 20,000 | $338K | 0.2% | $16.92 | $12.72 | +33.0% | COM | 45826J105 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 600 | $322K | 0.2% | $536.95 | $510.76 | +5.1% | COM | 558868105 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 5,000 | $320K | 0.2% | $63.95 | $40.11 | +59.4% | ORD SHS CL A | G52694109 |
| ALKS | ALKERMES PLC | 6,000 | $314K | 0.2% | $52.40 | $29.95 | +74.9% | SHS | G01767105 |
| TNGX | TANGO THERAPEUTICS INC | 10,000 | $313K | 0.2% | $31.26 | $13.93 | +124.4% | COM | 87583X109 |
| ARDX | ARDELYX INC | 60,000 | $306K | 0.2% | $5.10 | $6.62 | -22.9% | COM | 039697107 |
| VERA | VERA THERAPEUTICS INC | 7,000 | $300K | 0.2% | $42.91 | $35.52 | +20.8% | CL A | 92337R101 |
| MIRM | MIRUM PHARMACEUTICALS INC | 2,500 | $293K | 0.2% | $117.07 | $71.78 | +63.1% | COM | 604749101 |
| ORKA | ORUKA THERAPEUTICS INC | 3,000 | $286K | 0.2% | $95.17 | $34.76 | +173.8% | COM | 687604108 |
| SUPN | SUPERNUS PHARMACEUTICALS | 6,000 | $279K | 0.1% | $46.51 | $48.62 | -4.3% | COM | 868459108 |
| CRSP | CRISPR THERAPEUTICS AG | 5,000 | $273K | 0.1% | $54.54 | $59.89 | -8.9% | NAMEN AKT | H17182108 |
| ZYME | ZYMEWORKS INC | 10,000 | $261K | 0.1% | $26.14 | $21.81 | +19.8% | COM | 98985Y108 |
| KRYS | KRYSTAL BIOTECH INC | 692 | $257K | 0.1% | $371.67 | $298.78 | +24.4% | COM | 501147102 |
| CMPS | COMPASS PATHWAYS PLC | 18,000 | $255K | 0.1% | $14.15 | $6.73 | +110.4% | SPONSORED ADS | 20451W101 |
| XENE | XENON PHARMACEUTICALS INC | 4,200 | $254K | 0.1% | $60.36 | $42.00 | +43.7% | COM | 98420N105 |
| AXSM | AXSOME THERAPEUTICS INC. | 1,000 | $245K | 0.1% | $244.77 | $172.73 | +41.7% | COM | 05464T104 |
| AVBP | ARRIVENT BIOPHARMA INC | 7,041 | $245K | 0.1% | $34.74 | $29.51 | +17.7% | COM | 04272N102 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,500 | $244K | 0.1% | $97.48 | $38.77 | +151.4% | COM | 252828108 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 971 | $234K | 0.1% | $240.97 | $219.08 | +10.0% | SHS USD | G50871105 |
| KOD | KODIAK SCIENCES INC | 6,000 | $234K | 0.1% | $38.96 | $20.48 | +90.2% | COM | 50015M109 |
| RVMD | REVOLUTION MEDICINES INC | 1,200 | $225K | 0.1% | $187.28 | $146.07 | +28.2% | COM | 76155X100 |
| BBIO | BRIDGEBIO PHARMA INC | 3,000 | $223K | 0.1% | $74.48 | $65.64 | +13.5% | COM | 10806X102 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,000 | $222K | 0.1% | $111.03 | $90.41 | +22.8% | COM | 76243J105 |
| DNLI | DENALI THERAPEUTICS INC | 8,463 | $218K | 0.1% | $25.72 | $20.55 | +25.2% | COM | 24823R105 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 2,600 | $212K | 0.1% | $81.51 | $73.86 | +10.4% | COM | 04280A100 |
| SRRK | SCHOLAR ROCK HLDG CORP | 3,827 | $210K | 0.1% | $55.00 | $48.31 | +13.9% | COM | 80706P103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 5,000 | $203K | 0.1% | $40.63 | $28.84 | +40.9% | COM | 28036F105 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 10,838 | $195K | 0.1% | $17.96 | $13.58 | +32.2% | COM | 03237H101 |
| CTMX | CYTOMX THERAPEUTICS INC. | 39,400 | $148K | 0.1% | $3.75 | $3.82 | -1.8% | COM | 23284F105 |
| OCUL | OCULAR THERAPEUTIX INC | 15,000 | $147K | 0.1% | $9.82 | $12.15 | -19.2% | COM | 67576A100 |
| EYPT | EYEPOINT INC | 10,000 | $143K | 0.1% | $14.30 | $14.17 | +0.9% | COM NEW | 30233G209 |
| ORIC | ORIC PHARMACEUTICALS INC | 13,000 | $141K | 0.1% | $10.83 | $11.35 | -4.6% | COM | 68622P109 |
| OLMA | OLEMA PHARMACEUTICALS INC | 10,000 | $125K | 0.1% | $12.51 | $17.79 | -29.7% | COM | 68062P106 |